These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 7997185)
1. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). Merritt EA; Sixma TK; Kalk KH; van Zanten BA; Hol WG Mol Microbiol; 1994 Aug; 13(4):745-53. PubMed ID: 7997185 [TBL] [Abstract][Full Text] [Related]
2. Structural foundation for the design of receptor antagonists targeting Escherichia coli heat-labile enterotoxin. Merritt EA; Sarfaty S; Feil IK; Hol WG Structure; 1997 Nov; 5(11):1485-99. PubMed ID: 9384564 [TBL] [Abstract][Full Text] [Related]
3. Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Fan E; Merritt EA; Zhang Z; Pickens JC; Roach C; Ahn M; Hol WG Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):201-12. PubMed ID: 11173465 [TBL] [Abstract][Full Text] [Related]
4. Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists. Minke WE; Roach C; Hol WG; Verlinde CL Biochemistry; 1999 May; 38(18):5684-92. PubMed ID: 10231518 [TBL] [Abstract][Full Text] [Related]
5. Anchor-based design of improved cholera toxin and E. coli heat-labile enterotoxin receptor binding antagonists that display multiple binding modes. Pickens JC; Merritt EA; Ahn M; Verlinde CL; Hol WG; Fan E Chem Biol; 2002 Feb; 9(2):215-24. PubMed ID: 11880036 [TBL] [Abstract][Full Text] [Related]
6. Crystal structures exploring the origins of the broader specificity of escherichia coli heat-labile enterotoxin compared to cholera toxin. Holmner A; Mackenzie A; Okvist M; Jansson L; Lebens M; Teneberg S; Krengel U J Mol Biol; 2011 Feb; 406(3):387-402. PubMed ID: 21168418 [TBL] [Abstract][Full Text] [Related]
7. Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 A crystal structure reveals the details. Holmner A; Lebens M; Teneberg S; Angström J; Okvist M; Krengel U Structure; 2004 Sep; 12(9):1655-67. PubMed ID: 15341730 [TBL] [Abstract][Full Text] [Related]
8. Common architecture of the primary galactose binding sites of Erythrina corallodendron lectin and heat-labile enterotoxin from Escherichia coli in relation to the binding of branched neolactohexaosylceramide. Teneberg S; Berntsson A; Angström J J Biochem; 2000 Sep; 128(3):481-91. PubMed ID: 10965049 [TBL] [Abstract][Full Text] [Related]
9. Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin. Fan E; O'Neal CJ; Mitchell DD; Robien MA; Zhang Z; Pickens JC; Tan XJ; Korotkov K; Roach C; Krumm B; Verlinde CL; Merritt EA; Hol WG Int J Med Microbiol; 2004 Oct; 294(4):217-23. PubMed ID: 15532979 [TBL] [Abstract][Full Text] [Related]
10. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. Sixma TK; Kalk KH; van Zanten BA; Dauter Z; Kingma J; Witholt B; Hol WG J Mol Biol; 1993 Apr; 230(3):890-918. PubMed ID: 8478941 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Fukuta S; Magnani JL; Twiddy EM; Holmes RK; Ginsburg V Infect Immun; 1988 Jul; 56(7):1748-53. PubMed ID: 3290106 [TBL] [Abstract][Full Text] [Related]
12. Unexpected carbohydrate cross-binding by Escherichia coli heat-labile enterotoxin. Recognition of human and rabbit target cell glycoconjugates in comparison with cholera toxin. Karlsson KA; Teneberg S; Angström J; Kjellberg A; Hirst TR; Berström J; Miller-Podraza H Bioorg Med Chem; 1996 Nov; 4(11):1919-28. PubMed ID: 9007276 [TBL] [Abstract][Full Text] [Related]
13. Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism. O'Neal CJ; Amaya EI; Jobling MG; Holmes RK; Hol WG Biochemistry; 2004 Apr; 43(13):3772-82. PubMed ID: 15049684 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for differential receptor binding of cholera and Escherichia coli heat-labile toxins: influence of heterologous amino acid substitutions in the cholera B-subunit. Bäckström M; Shahabi V; Johansson S; Teneberg S; Kjellberg A; Miller-Podraza H; Holmgren J; Lebens M Mol Microbiol; 1997 May; 24(3):489-97. PubMed ID: 9179843 [TBL] [Abstract][Full Text] [Related]
15. Tumor marker disaccharide D-Gal-beta 1, 3-GalNAc complexed to heat-labile enterotoxin from Escherichia coli. van den Akker F; Steensma E; Hol WG Protein Sci; 1996 Jun; 5(6):1184-8. PubMed ID: 8762150 [TBL] [Abstract][Full Text] [Related]
16. Characterization and crystal structure of a high-affinity pentavalent receptor-binding inhibitor for cholera toxin and E. coli heat-labile enterotoxin. Merritt EA; Zhang Z; Pickens JC; Ahn M; Hol WG; Fan E J Am Chem Soc; 2002 Jul; 124(30):8818-24. PubMed ID: 12137534 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a new heat-labile enterotoxin, LT-IIb. van den Akker F; Sarfaty S; Twiddy EM; Connell TD; Holmes RK; Hol WG Structure; 1996 Jun; 4(6):665-78. PubMed ID: 8805549 [TBL] [Abstract][Full Text] [Related]
18. Structural studies of receptor binding by cholera toxin mutants. Merritt EA; Sarfaty S; Jobling MG; Chang T; Holmes RK; Hirst TR; Hol WG Protein Sci; 1997 Jul; 6(7):1516-28. PubMed ID: 9232653 [TBL] [Abstract][Full Text] [Related]
19. Novel carbohydrate binding site recognizing blood group A and B determinants in a hybrid of cholera toxin and Escherichia coli heat-labile enterotoxin B-subunits. Angström J; Bäckström M; Berntsson A; Karlsson N; Holmgren J; Karlsson KA; Lebens M; Teneberg S J Biol Chem; 2000 Feb; 275(5):3231-8. PubMed ID: 10652309 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc. Zalem D; Juhás M; Terrinoni M; King-Lyons N; Lebens M; Varrot A; Connell TD; Teneberg S Glycobiology; 2022 Apr; 32(5):391-403. PubMed ID: 34972864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]